India-Glycols-Value Unlocking At Play? NCLT approvals received for… — Stock market Stats — TG.ME

India-Glycols-Value Unlocking At Play? NCLT approvals received for restructuring Plans to demerge its bio-pharma and spirits/biofuel undertakings Sept 2 Record Date for Ennature Bio Pharma & IGL Spirits Demerger What's The Restructuring? India Glycols Ltd (specialty chemicals) IGL Spirits Ltd (spirits + biofuels) Ennature Bio Pharma (nutraceuticals/APIs) Ennature Bio Pharma: 1 share for every 3 India Glycols shares IGL Spirits: 1 share for every 1 India Glycols share Both resulting companies’ shares proposed to list on NSE and BSE What's The Impact? Eliminates Holding Co Discount Focus On Segments Further Value Unlocking What Are The Key Targets? Spirits business is targeting Rs 500cr+ EBITDA for FY27E Chemicals Business-Rs 2,500cr in revenue and Rs 400cr in EBITDA over 4-5 years. Ennature Bio Pharm-130-150cr in EBITDA in 4-5 years. Recent Triggers Focus on expanding green-technology based chemical products Industrial gases, and ethanol-linked biofuel capacities FY28 target for being debt free